Hydrophobically modified chitosan/gold nanoparticles for DNA delivery
Source abstract
Abstract
Present study dealt an application of modified chitosan gold nanoparticles (Nac-6-Au) for the immobilization of necked plasmid DNA. Gold nanoparticles stabilized with N-acylated chitosan were prepared by graft-onto approach. The stabilized gold nanoparticles were characterized by different physico-chemical techniques such as UV-vis, TEM, ELS and DLS. MTT assay was used for in vitro cytotoxicity of the nanoparticles into three different cell lines (NIH 3T3, CT-26 and MCF-7). The formulation of plasmid DNA with the nanoparticles corresponds to the complex forming capacity and in-vitro/in-vivo transfection efficiency was studied via gel electrophoresis and transfection methods, respectively. Results showed the modified chitosan gold nanoparticles were well-dispersed and spherical in shape with average size around 10∼12 nm in triple distilled water at pH 7.4, and showed relatively no cytotoxicity at low concentration. Addition of plasmid DNA on the aqueous solution of the nanoparticles markedly reduced surface potential (50.0∼66.6%) as well as resulted in a 13.33% increase in hydrodynamic diameters of the formulated nanoparticles. Transfection efficiency of Nac-6-Au/DNA was dependent on cell type, and higher β-galactosidase activity was observed on MCF-7 breast cancer cell. Typically, this activity was 5 times higher in 4.5 mg/ml nanoparticles concentration than that achieved by the nanoparticles of other concentrations (and/or control). However, this activity was lower in in-vitro and dramatically higher in in-vivo than that of commercially available transfection kit (Lipofectin®) and DNA. From these results, it can be expected to develop alternative new vectors for gene delivery.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Artursson P, Lindmark T, Davis SS, Illum L (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11:1358–136110.1023/A:1018967116988 ↗
2. Ana Y, Zhaia P, Dashtia AM, Wua S, Lina X, Wub MA (2002) Combined gene delivery by co-transduction of adenoviral and retroviral vectors for cancer gene therapy. Cancer Lett 184:179–18810.1016/S0304-3835(02)00241-0 ↗
3. Aral C, Akbuga J (1999) Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA: poly (l-lysine) complexes. J Pharm Sci 6:73–82
4. Aryal S, KC RB, Dharmaraj N, Bhattarai N, Kim CH, Kim HY (2006) Spectroscopic identification of S–Au interacton in cysteine capped gold nanoparticles. Spectrochimica Acta Part A 63:160–16310.1016/j.saa.2005.04.048 ↗
5. Bhattarai N, Bhattarai SR, Yi HK, Lee JC, Khil MS, Hwang PH, Kim HY (2003) Novel polymeric micelles of amphiphilic triblock copolymer poly (p-Dioxanone-co-l-Lactide)-block-Poly (ethylene glycol). Pharm Res 20:2021–202710.1023/B:PHAM.0000008052.25673.a9 ↗
6. Bhattarai SR, Yi HK, Bhattarai N, Hwang PH, Kim HY (2006) Novel block copolymer (PPDO/PLLA-b-PEG): Enhancement of DNA uptake and cell transfection. Acta Biomaterialia 2:207–21210.1016/j.actbio.2005.10.007 ↗
7. Chae SY, Son S, Lee M, Jang MK, Nah JW (2005) Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier. J Control Release 109:330–33410.1016/j.jconrel.2005.09.040 ↗
8. Corsi K, Chellat F, Yahia H, Fernades JC (2003) Mesenchymal stem cells, MG63 and HEK293 Transfection using chitosan-DNA nanoparticles. Biomaterials 24:1255–126410.1016/S0142-9612(02)00507-0 ↗
9. Chakrabarti R, Klibanov AM (2003) Nanocrystals modified with peptide nucleic acids (PNAs) for selective self-assembly and DNA detection. J Am Chem Soc 125:12531–1254010.1021/ja035399g ↗
10. Daniel MC, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties. Chem Rev 104:293–34610.1021/cr030698+ ↗
11. Ferrari S, Duncan GM, Alton WFW (2002) Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Delivery Rev 54:1373–139310.1016/S0169-409X(02)00145-X ↗
12. Iqbal M, Lin W, Jabbal-Gill I, Davis SS, Steward MW, Illum L (2003) Nasal delivery of chitosan–DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine 21:1478–148510.1016/S0264-410X(02)00662-X ↗
13. Ishii T, Okahata Y, Sato T (2001) Mechanism of cell transfection with plasmid/chitosan complexes. BBA-Biomembranes 1514:51–6410.1016/S0005-2736(01)00362-5 ↗
14. Kai E, Ochiya T (2004) A method for oral DNA delivery with N-Acetylated Chitosan. Pharm Res 21:838–84310.1023/B:PHAM.0000026437.32238.6f ↗
15. KC RB, Aryal S, Bhattarai SR, Bhattarai N, Kim CH, Kim HY (2006) Stabilization of gold nanoparticles by hydrophobically modified polycations. J Biomater Sci Polym Ed 17(5):576–589
16. Kim TH, Park IK, Nah JW, Choi YJ, Cho CS (2004) Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials 25:3783–379210.1016/j.biomaterials.2003.10.063 ↗
17. Koping-Hoggard M, Guan IT, Edwards K, Nilsson M, Varum KM, Artursson P (2001) Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Therapy 8:1108–112110.1038/sj.gt.3301492 ↗
18. Kulmeet IS, Catherine MM, Joseph MS, Sallie WS, Vincent MR (2002) Gold nanoparticles mediated transfection of mammalian cells. Bioconjugate Chememistry 13:3–610.1021/bc015545c ↗
19. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY (1998) Reparation of chitosan self-aggregates as a gene delivery system. J Control Release 51:213–22010.1016/S0168-3659(97)00173-9 ↗
20. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT (1998) DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53:183–19310.1016/S0168-3659(97)00252-6 ↗
21. Lundstrom K (2003) Latest development in viral vectors for gene therapy. Trends Biotechnol 21:117–12210.1016/S0167-7799(02)00042-2 ↗
22. Le Tien C, Lacroix M, Ispas-Szabo P, Mateescu MA (2003) N-acylated chitosan: hydrophobic matrices for controlled drug release. J Control Release 93:1–1310.1016/S0168-3659(03)00327-4 ↗
23. Maclaughlin FC, Mumper RJ, Wang J et al (1998) Chitosan and de-polymerized chitosan oligomers as condensing carriers for in vivo plasmid deliver. J Control Release 56:259–27210.1016/S0168-3659(98)00097-2 ↗
24. Mao HQ, Roy K, Troung-Le VL, Janes KA et al (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and Transfection efficiency. J Control Release 70:399–42110.1016/S0168-3659(00)00361-8 ↗
25. Park IK, Kim TH, Park YH, Shin BA, Choi ES et al (2001) Galactosylated chitosan-graft-poly (ethylene glycol) as hepatocyte-targeting DNA carrier. J Control Release 76:349–36210.1016/S0168-3659(01)00448-5 ↗
26. Pertmer TM, Eisenbraun DM, McCabe D, Prayaga SK, Haynes JR (1995) Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13:1427–143010.1016/0264-410X(95)00069-D ↗
27. Quong D, Yeo JN, Neufeld RJ (1999) Stability of chitosan and poly-l-lysine membrane coating DNA-alginate beads when exposed to hydrolytic enzymes. J Microencapsulation 16:73–8210.1080/026520499289329 ↗
28. Quong D, Neufeld R (1998) DNA protection from extracapsular nucleases, within chitosan or poly-l-lysine-coated alginate beads. J Biotechnol Bioeng 60:124–13410.1002/(SICI)1097-0290(19981005)60:1<124::AID-BIT14>3.0.CO;2-Q ↗
29. Ravi Kumar MNV, Bakowsky U, Lehr CM (2004) Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 25:1771–177710.1016/j.biomaterials.2003.08.069 ↗
30. Roy K, Mao HQ, Huang SK, Leong KW (1999) Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Med 5:387–39110.1038/7385 ↗
31. Ruponena M, Honkakoskia P, Ronkko S, Pelkonenb J, Tammic M, Urtti A (2003) Extracellular and intracellular barriers in non-viral gene delivery. J Control Release 93:213–21710.1016/j.jconrel.2003.08.004 ↗
32. Schuber F, Kichler A, Boeckler C, Frisch B (1998) Liposomes: from membrane models to gene therapy. Pure Appl Chem 70:89–9610.1351/pac199870010089 ↗
33. Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G (2002) Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 23:153–15910.1016/S0142-9612(01)00090-4 ↗
34. Tripathy SK, Black HB, Goldwasser E, Leiden JM (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545–55010.1038/nm0596-545 ↗